A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study .

导出原文传递

翻译打印收藏纠错

作者： Giles FJ ^[1] ; ol.com ; Shan J ; Advani SH ; Akan H ; Aydogdu I ; Aziz Z ; Azim HA ; Bapsy PP ; Buyukkececi F ; Chaimongkol B ; Chen PM ; Cheong SK ; Ferhanoglu B ; Hamza R ; Khalid HM ; Intragumtornchai T ; Kim SW ; Kim SY ; Koc H ; Kumar L ; Kumar R ; Lei KI ; Lekhakula A ; Muthalib A ; Patel M ; Poovalingam VP ; Prayoonwiwat W ; Rana F ; Reksodiputro AH ; Ruff P ; Sagar TG ; Schwarer AP ; Song HS ; Suh CW ; Suharti C ; Supindiman I ; Tee GY ; Thamprasit T ; Villalon AH ; Wickham NR ; Wong JE ; Yalcin A ; Jootar S

作者单位： International Oncology Study Group, Houston, Texas, USA. frankgiles ^[1]

关键词 Antineoplastic Agents Combined Interferon Alfa-2b Lymphoma Non Hodgkin drug therapy 抗肿瘤药多剂联用干扰素ALFA-2B

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交